UNRESECTABLE LIPOSARCOMA
Clinical trials for UNRESECTABLE LIPOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LIPOSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets rare sarcomas
Disease control OngoingThis early-stage study tests a new drug called BTX-A51 in 24 people with advanced liposarcoma that has spread or come back. The main goal is to check if the drug is safe and tolerable at two different doses. Researchers will also watch for any tumor shrinkage or slowing of the di…
Matched conditions: UNRESECTABLE LIPOSARCOMA
Phase: PHASE1 • Sponsor: Michael Wagner, MD • Aim: Disease control
Last updated May 17, 2026 10:10 UTC
-
New drug cocktail shows promise against rare sarcomas
Disease control OngoingThis study tests whether adding the drug cabozantinib to a standard immunotherapy combination (ipilimumab and nivolumab) works better than immunotherapy alone for people with advanced soft tissue sarcoma. About 66 adults with specific sarcoma types that have spread or cannot be r…
Matched conditions: UNRESECTABLE LIPOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute LAO • Aim: Disease control
Last updated May 11, 2026 20:46 UTC